Verrica Pharmaceuticals


ASP | WAC | AWP at the HCPCS Unit


Verrica Pharmaceuticals

Ycanth HCPCS:


HCPCS Code Descriptor:

Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)


C Code

Ycanth NDCs:

No actively aligned NDCs found

Primary Type:

Topical keratolytics

Generic/Specialty Status:


Package Type:

Pf Appli

Route of Administration:

Topical application

Ycanth CPT Codes:

Potential CPT administration codes for Ycanth can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ycanth:

YCANTH is a Topical keratolytics drug manufactured by Verrica Pharmaceuticals and administered via the Topical application route of administration. The C Code: C9164 is aligned to the drug YCANTH.

Ycanth is a topical skin solution used to treat molluscum contagiosum. Molluscum contagiosum is a viral skin disease that causes raised lesions that can appear flesh colored or pink. These lesions are called Mollusca, and they can cause pain, inflammation, itching, and bacterial infection. Ycanth can be applied by a healthcare provider once every three weeks to the skin to help treat the disease.


C9164 Added Date:

January 1, 2024

C9164 Effective Date:

January 1, 2024

C9164 Termination Date:

April 1, 2024

Ycanth billing and coding information can be found through Verrica Pharmaceuticals at the link below:
Ycanth patient assistance information can be found through Verrica Pharmaceuticals at the URL:
YCANTH prescribing information can be found at the link below:
Information regarding YCANTH’s side effects can be found at MedlinePlus Drug Alert: